Genetic Variation in P2rx7 and Pain Tolerance

Autor: Eija Kalso, Tom Wilsgaard, Bendik S. Winsvold, Oleg Kambur, Mari A. Kaunisto, Audun Stubhaug, Christopher Sivert Nielsen, John-Anker Zwart
Přispěvatelé: Department of Pharmacology, Medicum, Faculty of Medicine, University of Helsinki, Institute for Molecular Medicine Finland, Helsinki Institute of Life Science HiLIFE, Eija Kalso / Principal Investigator, Department of Diagnostics and Therapeutics, Clinicum, Anestesiologian yksikkö, HUS Perioperative, Intensive Care and Pain Medicine
Jazyk: angličtina
Rok vydání: 2018
Předmět:
0301 basic medicine
Oncology
Male
Pain tolerance
DNA Mutational Analysis
ION-CHANNEL
SUSCEPTIBILITY
VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Nevrologi: 752
Cohort Studies
Experimental pain
0302 clinical medicine
P2X7 RECEPTOR
Young adult
POPULATION
Pain Measurement
education.field_of_study
NEUROPATHIC PAIN
Chronic pain
Cold pressor test
P2X(7) RECEPTOR
ASSOCIATION
Middle Aged
Cold-pressor test
Neurology
Neuropathic pain
Female
SENSITIVITY
P2X7
Research Paper
Adult
Pain Threshold
medicine.medical_specialty
GAIN-OF-FUNCTION
Adolescent
Genotype
Population
Pain
SNP
Community Health Planning
03 medical and health sciences
Young Adult
Breast cancer
Sex Factors
Internal medicine
medicine
Humans
Polymorphism
education
Aged
business.industry
Genetic Variation
P2RX7
medicine.disease
3126 Surgery
anesthesiology
intensive care
radiology

030104 developmental biology
Anesthesiology and Pain Medicine
Cross-Sectional Studies
VDP::Medical disciplines: 700::Clinical medical disciplines: 750::Neurology: 752
Neurology (clinical)
Receptors
Purinergic P2X7

business
030217 neurology & neurosurgery
Zdroj: Pain
ISSN: 0304-3959
Popis: Supplemental Digital Content is Available in the Text. Variation in the P2RX7-gene, particularly single-nucleotide polymorphism rs7958311, may modulate human pain sensitivity in experimental and clinical pain phenotypes.
P2X7 is a nonselective cation channel activated by extracellular ATP. P2X7 activation contributes to the proinflammatory response to injury or bacterial invasion and mediates apoptosis. Recently, P2X7 function has been linked to chronic inflammatory and neuropathic pain. P2X7 may contribute to pain modulation both by effects on peripheral tissue injury underlying clinical pain states, and through alterations in central nervous system processing, as suggested by animal models. To further test its role in pain sensitivity, we examined whether variation within the P2RX7 gene, which encodes the P2X7 receptor, was associated with experimentally induced pain in human patients. Experimental pain was assessed in Tromsø 6, a longitudinal and cross-sectional population-based study (N = 3016), and the BrePainGen cohort, consisting of patients who underwent breast cancer surgery (N = 831). For both cohorts, experimental pain intensity and tolerance were assessed with the cold-pressor test. In addition, multisite chronic pain was assessed in Tromsø 6 and pain intensity 1 week after surgery was assessed in BrePainGen. We tested whether the single-nucleotide polymorphism rs7958311, previously implicated in clinical pain, was associated with experimental and clinical pain phenotypes. In addition, we examined effects of single-nucleotide polymorphisms rs208294 and rs208296, for which previous results have been equivocal. Rs7958311 was associated with experimental pain intensity in the meta-analysis of both cohorts. Significant associations were also found for multisite pain and postoperative pain. Our results strengthen the existing evidence and suggest that P2X7 and genetic variation in the P2RX7-gene may be involved in the modulation of human pain sensitivity.
Databáze: OpenAIRE